DO34 analog

• Description :

  DO34 analog is a triazole DAGL (α) inhibitor extracted from patent WO2017096315 A1, compound 100.

• Product Name Alternative :

  PK-8165

• UNSPSC :

  12352005

• Target :

  DAGL

• Type :

  Reference compound

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Metabolic Disease

• Assay Protocol :

  https://www.medchemexpress.com/DO34_analog.html

• Purity :

  98.42

• Solubility :

  DMSO : ≥ 105 mg/mL

• Smiles :

  O=C(N1C(CC2=CC=CC=C2)CN(C(OC(C)(C)C)=O)CC1)N3N=CC(C4=CC=C(OC(F)(F)F)C=C4)=N3

• Molecular Formula :

  C26H28F3N5O4

• Molecular Weight :

  531.53

• References & Citations :

  [1]WO 2017096315 A1.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [2098969-71-0]